4//SEC Filing
Coleman Mark 4
Accession 0001209191-23-049648
CIK 0001579428other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:30 PM ET
Size
10.8 KB
Accession
0001209191-23-049648
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Exercise/Conversion
Common Stock
2023-09-15$3.67/sh+11,016$40,429→ 36,113 total - Sale
Common Stock
2023-09-15$75.19/sh−11,016$828,241→ 25,097 total - Sale
Common Stock
2023-09-15$75.18/sh−18,572$1,396,189→ 403,856 total(indirect: See Footnote) - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-15−11,016→ 0 totalExercise: $3.67From: 2015-09-16Exp: 2024-09-16→ Common Stock (11,016 underlying)
Footnotes (4)
- [F1]Represents an exercise of stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- [F4]Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001658379
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 6:30 PM ET
- Size
- 10.8 KB